{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:47:39Z","timestamp":1759009659808},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Splenectomy remains a common approach for the management of hypersplenism and portal hypertension in hepatitis B virus (HBV)-associated cirrhotic patients in China and some other Asian countries. The effects of antiviral therapy on the survival and occurrence of complications in asplenic HBV-associated cirrhotic patients are unknown. This study analyzed the effect of antiviral therapy on survival and occurrence of major complications in HBV-associated cirrhotic patients after splenectomy for hypersplenism and portal hypertension.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 57 eligible patients for analysis, 28 patients received nucleos(t)ide analogs (treatment group) for antiviral treatment after splenectomy, while 29 patients received no antiviral treatment (control group). After a median of 3 years and 9 months, the overall survival and complication-free survival in the treatment group were higher though not statistically significant than those in the control group. Multivariate analysis showed that antiviral treatment was associated with increased but not statistically significant overall survival (hazard ratio (HR): 2.272, 95% confidence interval (CI): 0.952\u20135.424,<jats:italic>P<\/jats:italic>\u2009=\u20090.064) and the antiviral treatment was significantly associated with increased complication-free survival of the patients (HR: 7.229, 95% CI: 1.271\u201341.117,<jats:italic>P<\/jats:italic>\u2009=\u20090.026). The complication-free survival in patients aged\u2009\u2264\u200940 years was higher than that in patients aged\u2009&gt;\u200940 years in the antiviral treatment patients (<jats:italic>P<\/jats:italic>\u2009=\u20090.020).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Antiviral therapy initiating after splenectomy may reduce the incidence of complications and tend to improve the survival in asplenic HBV-associated cirrhotic patients, especially in younger patients, supporting the use of antiviral therapy in these patients after splenectomy.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1743-422x-9-273","type":"journal-article","created":{"date-parts":[[2012,11,16]],"date-time":"2012-11-16T15:14:23Z","timestamp":1353078863000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect of antiviral therapy on the survival and incidence of major complications in HBV-associated cirrhotic patients after splenectomy for hypersplenism and portal hypertension"],"prefix":"10.1186","volume":"9","author":[{"given":"Ningqiang","family":"Tian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingbo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qunying","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yawen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanfan","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,16]]},"reference":[{"key":"1959_CR1","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/hep.23190","volume":"50","author":"AS Lok","year":"2009","unstructured":"Lok AS, McMahon BJ: Chronic hepatitis B: update 2009. Hepatology. 2009, 50: 661-662. 10.1002\/hep.23190.","journal-title":"Hepatology"},{"key":"1959_CR2","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1056\/NEJMoa033364","volume":"351","author":"YF Liaw","year":"2004","unstructured":"Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, Tanwandee T, Tao QM, Shue K, Keene ON, Dixon JS, Gray DF, Sabbat J: Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med. 2004, 351: 1521-1531. 10.1056\/NEJMoa033364.","journal-title":"N Engl J Med"},{"key":"1959_CR3","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1002\/hep.21939","volume":"46","author":"MF Yuen","year":"2007","unstructured":"Yuen MF, Fong DY, Wong DK, Yuen JC, Fung J, Lai CL: Hepatitis B virus DNA levels at week 4 of lamivudine treatment predict the 5-year ideal response. Hepatology. 2007, 46: 1695-1703. 10.1002\/hep.21939.","journal-title":"Hepatology"},{"key":"1959_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/hep.510310130","volume":"31","author":"JP Villeneuve","year":"2000","unstructured":"Villeneuve JP, Condreay LD, Willems B, Pomier-Layrargues G, Fenyves D: Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B. Hepatology. 2000, 31: 207-210. 10.1002\/hep.510310130.","journal-title":"Hepatology"},{"key":"1959_CR5","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1111\/j.1572-0241.2006.00769.x","volume":"101","author":"F Kanwal","year":"2006","unstructured":"Kanwal F, Farid M, Martin P, Chen G, Gralnek IM, Dulai GS, Spiegel BM: Treatment alternatives for hepatitis B cirrhosis: a cost-effectiveness analysis. Am J Gastroenterol. 2006, 101: 2076-2089. 10.1111\/j.1572-0241.2006.00769.x.","journal-title":"Am J Gastroenterol"},{"key":"1959_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1478-3231.2008.01828.x","volume":"29","author":"JH Kim","year":"2009","unstructured":"Kim JH, Park JW, Koh DW, Lee WJ, Kim CM: Efficacy of lamivudine on hepatitis B viral status and liver function in patients with hepatitis B virus-related hepatocellular carcinoma. Liver Int. 2009, 29: 203-207. 10.1111\/j.1478-3231.2008.01828.x.","journal-title":"Liver Int"},{"key":"1959_CR7","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1111\/j.1440-1746.2006.04707.x","volume":"22","author":"T Kuzuya","year":"2007","unstructured":"Kuzuya T, Katano Y, Kumada T, Toyoda H, Nakano I, Hirooka Y, Itoh A, Ishigami M, Hayashi K, Honda T, Goto H: Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma. J Gastroenterol Hepatol. 2007, 22: 1929-1935. 10.1111\/j.1440-1746.2006.04707.x.","journal-title":"J Gastroenterol Hepatol"},{"key":"1959_CR8","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1001\/archsurg.2011.125","volume":"146","author":"AC Chan","year":"2011","unstructured":"Chan AC, Chok KS, Yuen WK, Chan SC, Poon RT, Lo CM, Fan ST: Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma. Arch Surg. 2011, 146: 675-681. 10.1001\/archsurg.2011.125.","journal-title":"Arch Surg"},{"key":"1959_CR9","first-page":"835","volume":"56","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Wen T, Yan L, Chen Z, Yang H, Deng X, Liang G, Li G, Zhang X, Ran S, Liao Z: The changes of hepatic hemodynamics and functional hepatic reserve after splenectomy with periesophagogastric devascularization. Hepatogastroenterology. 2009, 56: 835-839.","journal-title":"Hepatogastroenterology"},{"key":"1959_CR10","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/0002-9610(82)90554-2","volume":"144","author":"NJ Soper","year":"1982","unstructured":"Soper NJ, Rikkers LF: Effect of operations for variceal hemorrhage on hypersplenism. Am J Surg. 1982, 144: 700-703. 10.1016\/0002-9610(82)90554-2.","journal-title":"Am J Surg"},{"key":"1959_CR11","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S1072-7515(00)00735-3","volume":"191","author":"M Tomikawa","year":"2000","unstructured":"Tomikawa M, Hashizume M, Saku M, Tanoue K, Ohta M, Sugimachi K: Effectiveness of gastric devascularization and splenectomy for patients with gastric varices. J Am Coll Surg. 2000, 191: 498-503. 10.1016\/S1072-7515(00)00735-3.","journal-title":"J Am Coll Surg"},{"key":"1959_CR12","first-page":"1407","volume":"55","author":"K Murata","year":"2008","unstructured":"Murata K, Ito K, Yoneda K, Shiraki K, Sakurai H, Ito M: Splenectomy improves liver function in patients with liver cirrhosis. Hepatogastroenterology. 2008, 55: 1407-1411.","journal-title":"Hepatogastroenterology"},{"key":"1959_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000321886","volume":"28","author":"Y Ushitora","year":"2011","unstructured":"Ushitora Y, Tashiro H, Takahashi S, Amano H, Oshita A, Kobayashi T, Chayama K, Ohdan H: Splenectomy in chronic hepatic disorders: portal vein thrombosis and improvement of liver function. Dig Surg. 2011, 28: 9-14. 10.1159\/000321886.","journal-title":"Dig Surg"},{"key":"1959_CR14","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1007\/s10620-006-9712-1","volume":"52","author":"N Assy","year":"2007","unstructured":"Assy N, Gefen H, Schlesinger S, Karim W: Reactivation versus primary CMV infection after splenectomy in immunocompetent patients. Dig Dis Sci. 2007, 52: 3477-3479. 10.1007\/s10620-006-9712-1.","journal-title":"Dig Dis Sci"},{"issue":"5N","key":"1959_CR15","first-page":"33N","volume":"88","author":"B Styrt","year":"1990","unstructured":"Styrt B: Infection associated with asplenia: risks, mechanisms, and prevention. Am J Med. 1990, 88 (5N): 33N-42N.","journal-title":"Am J Med"},{"key":"1959_CR16","doi-asserted-by":"publisher","first-page":"e17302","DOI":"10.1371\/journal.pone.0017302","volume":"6","author":"AJ Lammers","year":"2011","unstructured":"Lammers AJ, Hoekstra JB, Speelman P, Lombarts KM: Physicians report barriers to deliver best practice care for asplenic patients: a cross-sectional survey. PLoS One. 2011, 6: e17302-10.1371\/journal.pone.0017302.","journal-title":"PLoS One"},{"key":"1959_CR17","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/S0168-8278(94)80115-0","volume":"21","author":"G Realdi","year":"1994","unstructured":"Realdi G, Fattovich G, Hadziyannis S, Schalm SW, Almasio P, Sanchez-Tapias J, Christensen E, Giustina G, Noventa F: Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. J Hepatol. 1994, 21: 656-666. 10.1016\/S0168-8278(94)80115-0.","journal-title":"J Hepatol"},{"key":"1959_CR18","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/0016-5085(92)91188-A","volume":"103","author":"FE de Jongh","year":"1992","unstructured":"de Jongh FE, Janssen HL, de Man RA, Hop WC, Schalm SW, van Blankenstein M: Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. Gastroenterology. 1992, 103: 1630-1635.","journal-title":"Gastroenterology"},{"issue":"Suppl 3","key":"1959_CR19","doi-asserted-by":"publisher","first-page":"S333","DOI":"10.1046\/j.1440-1746.17.s3.23.x","volume":"17","author":"YF Liaw","year":"2002","unstructured":"Liaw YF: Management of YMDD mutations during lamivudine therapy in patients with chronic hepatitis B. J Gastroenterol Hepatol. 2002, 17 (Suppl 3): S333-S337.","journal-title":"J Gastroenterol Hepatol"},{"key":"1959_CR20","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1177\/135965350400900621","volume":"9","author":"SK Fung","year":"2004","unstructured":"Fung SK, Lok AS: Management of hepatitis B patients with antiviral resistance. Antivir Ther. 2004, 9: 1013-1026.","journal-title":"Antivir Ther"},{"key":"1959_CR21","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1002\/hep.20939","volume":"42","author":"P Lampertico","year":"2005","unstructured":"Lampertico P, Vigan\u00f2 M, Manenti E, Iavarone M, Lunghi G, Colombo M: Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine. Hepatology. 2005, 42: 1414-1419. 10.1002\/hep.20939.","journal-title":"Hepatology"},{"key":"1959_CR22","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jhep.2007.12.026","volume":"48","author":"JJ Sung","year":"2008","unstructured":"Sung JJ, Lai JY, Zeuzem S, Chow WC, Heathcote EJ, Perrillo RP, Brosgart CL, Woessner MA, Scott SA, Gray DF, Gardner SD: Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B. J Hepatol. 2008, 48: 728-735. 10.1016\/j.jhep.2007.12.026.","journal-title":"J Hepatol"},{"key":"1959_CR23","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/hep.21253","volume":"44","author":"F van B\u00f6mmel","year":"2006","unstructured":"van B\u00f6mmel F, Z\u00f6llner B, Sarrazin C, Spengler U, H\u00fcppe D, M\u00f6ller B, Feucht HH, Wiedenmann B, Berg T: Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy. Hepatology. 2006, 44: 318-325. 10.1002\/hep.21253.","journal-title":"Hepatology"},{"key":"1959_CR24","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s10096-010-1049-1","volume":"29","author":"AP de Porto","year":"2010","unstructured":"de Porto AP, Lammers AJ, Bennink RJ, ten Berge IJ, Speelman P, Hoekstra JB: Assessment of splenic function. Eur J Clin Microbiol Infect Dis. 2010, 29: 1465-1473. 10.1007\/s10096-010-1049-1.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1959_CR25","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0140-6736(10)61493-6","volume":"378","author":"A Di Sabatino","year":"2011","unstructured":"Di Sabatino A, Carsetti R, Corazza GR: Post-splenectomy and hyposplenic states. Lancet. 2011, 378: 86-97. 10.1016\/S0140-6736(10)61493-6.","journal-title":"Lancet"},{"key":"1959_CR26","doi-asserted-by":"publisher","first-page":"e23164","DOI":"10.1371\/journal.pone.0023164","volume":"6","author":"PU Cameron","year":"2011","unstructured":"Cameron PU, Jones P, Gorniak M, Dunster K, Paul E, Lewin S, Woolley I, Spelman D: Splenectomy associated changes in IgM memory B cells in an adult spleen registry cohort. PLoS One. 2011, 6: e23164-10.1371\/journal.pone.0023164.","journal-title":"PLoS One"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-9-273.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T20:41:13Z","timestamp":1687812073000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-9-273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,16]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1959"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-9-273","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,16]]},"assertion":[{"value":"22 January 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"273"}}